ACADIA Pharmaceuticals ACAD reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
ACADIA Pharmaceuticals beat estimated earnings by 16.0%, reporting an EPS of $-0.21 versus an estimate of $-0.25.
Revenue was up $19.34 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 5.33% drop in the share price the next day.
Here's a look at ACADIA Pharmaceuticals's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.